This role is a key position within the Life Science Operations & Innovation FP& A organization, responsible for all aspects of consolidated Cost of Goods Sold (COGS) reporting across the Genomics, Stem Cell, Gamete businesses, and QA Life Sciences. The role reports directly to the Director of Life Science Operations & Innovation and collaborates closely with the Global FP& A team, the corporate accounting organization, and cross functional business partners throughout the company.

The FP& A Manager, Life Science Operations helps lead the monthly and quarterly financial planning and forecasting processes for Life Science Operations. This role oversees the full planning lifecycle, including establishing calendars and milestones, developing and maintaining master templates, and delivering timely, high-quality variance analysis and financial commentary for the annual operating plan, recurring forecasts, and actual results. Beyond core FP& A responsibilities, this position provides essential support for the Life Science Capital Expenditure (CapEx) process and lead the standard cost process for Stem Cell and Genomics.

Success in this role requires strong proficiency in financial consolidation systems (e.g., HFM, Adaptive, or comparable tools) and a solid understanding of manufacturing cost structures, operational drivers, and how cost flows operate within a production environment.

About Cooper Surgical: CooperSurgical is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most in life. As a division of Cooper Companies, we're driven by a unified purpose to enable patients to experience life's beautiful moments. Guided by our shared values - dedicated, innovative, friendly, partners, and do the right thing - our offerings support patients throughout their lifetimes, from contraception to fertility and birth solutions, to women's and family care, and beyond. We currently offer over 600 clinically relevant medical devices to healthcare providers, including testing and treatment options, as well as an innovative suite of assisted reproductive technology and genomic testing solutions. Learn more atwww.coopersurgical.com.